This inventor holds 1 USPTO granted patent. Top assignee: Boryung Pharmaceutical Co., Ltd.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Kun Ja Lee: Innovator in Pyrimidinone Derivatives
Introduction
Kun Ja Lee is a notable inventor based in Kyungki-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his work on pyrimidinone derivatives. His innovative approach has led to the development of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Kun Ja Lee holds a patent for pyrimidinone derivatives. This invention represents a crucial step in the development of new pharmaceutical compounds that may have various applications in medicine. His work in this area highlights the importance of innovation in addressing health challenges.
Career Highlights
Kun Ja Lee is associated with Boryung Pharmaceutical Co., Ltd., where he continues to contribute to the field of pharmaceutical research and development. His role in the company allows him to collaborate with other talented professionals and push the boundaries of what is possible in drug development.
Collaborations
Some of his notable coworkers include Woo Hyun Paik and Ji Han Kim. Together, they work on various projects that aim to enhance the efficacy and safety of pharmaceutical products.
Conclusion
Kun Ja Lee's contributions to the field of pharmaceuticals through his patent on pyrimidinone derivatives exemplify the impact of innovation in medicine. His work at Boryung Pharmaceutical Co., Ltd. and collaborations with esteemed colleagues further underscore his commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile